Early Prostate-Specific Antigen Changes and Clinical Outcome After

Autor:	Andrei, Gafita, Matthias M, Heck, Isabel, Rauscher, Robert, Tauber, Lisena, Cala, Charlott, Franz, Calogero, D'Alessandria, Margitta, Retz, Wolfgang A, Weber, Matthias, Eiber
Rok vydání:	2019
Předmět:	Glutamate Carboxypeptidase II Male Radioisotopes Prostatic Neoplasms Castration-Resistant Antigens Surface Humans Lutetium Neoplasm Metastasis Prostate-Specific Antigen Aged Retrospective Studies
Zdroj:	Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 61(10)
ISSN:	1535-5667
Popis:	Prostate-specific antigen (PSA) is widely used to monitor treatment response in patients with metastatic castration-resistant prostate cancer. However, PSA measurements are considered only after 12 wk of treatment. We aimed to evaluate the prognostic value of early PSA changes after
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::4cd86aa49cd15f70552f07db30f66bad https://pubmed.ncbi.nlm.nih.gov/32111687 Zobrazit plný text záznamu